Skip to content

McGraw Hill

US · MH #2645 by market cap Listed 2025
12.05 +0.23 +1.95%
Periodic snapshot; not a real-time feed. · 2026-11-20 16:10

Price chart

After-hours 12.05 0.00%
14.809.1012.052026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on MH?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Neutral
  • Recent price momentum is -16.9% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Short interest has fallen to 1.4% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Bearish
  • Price is below its 20-day average and below its 60-day average.
  • The 20-day average is below the 60-day average, a short-term downtrend.
Quant Rating, last 30 days C → E

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2848 U.S. stocks StockVane covers.

Last computed: 2026-11-22 08:27 UTC

Data coverage: 6 of 6 factors. Missing data is not a zero score.

Overall B
ValuationGrowthProfitMomentumHealthAnalyst
Valuation A

How expensive the stock is versus earnings, sales and its own 5-year history.

Forward P/E 11.5x Better than 70%
Price / Sales 1.1x Better than 76%
Growth C

How fast revenue, profit and free cash flow are compounding.

Revenue CAGR (3Y) 2.6% Better than 37%
Free cash flow CAGR (3Y) 3.1% Better than 42%
Profitability B-

How much profit the business keeps from each dollar of sales and capital.

Gross margin 80.9% Better than 91%
Operating margin 15.0% Better than 65%
Net margin 1.7% Better than 31%
Return on equity 7.0% Better than 42%
Return on invested capital 1.0% Better than 31%
Momentum C+

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return -9.4% Better than 52%
6-month return 0.2% Better than 56%
12-month return (ex latest month) -12.1% Better than 21%
Distance below 52-week high 33.1% Better than 38%
Financial Health C

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 0.8x Better than 10%
Debt to assets 48.2% Better than 17%
Free cash flow / net income 360.4% Better than 89%
Analyst View B+

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 87.5% Better than 69%
Upside to average target 35.2% Better than 54%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W +3.88%
1M -15.56%
3M -6.30%
6M -1.87%
YTD -26.97%
1Y -27.54%

Key statistics

Price & volume

Prev close
11.82
Open
12.03
Day range
11.93 - 12.59
Avg price
12.16
Volume
1.02M
Turnover
12.40M
Amplitude
5.58%
52-week range
8.95 - 18.00

Valuation

P/E
65.14
P/E (TTM)
-48.59
P/B
2.63
EPS
0.19
Net profit
35.40M
Net assets
877.03M

Share structure

Market cap
2.31B
Float cap
287.81M
Shares out
191.32M
Float shares
23.88M

Dividend & listing

Dividend (TTM)
0.00
Listing date
2025-07-24
52-week range 34% of range
8.95 18.00

33.1% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-7.78M net over the window

Short interest

Shares short
2.63M
As of
2026-10-30

Frequently asked questions

What is the current stock price of McGraw Hill (MH)?

McGraw Hill last traded at 12.05. This page shows a periodic quote snapshot. Check the displayed quote time.

What is McGraw Hill's market cap?

About 2.31B.

What is the P/E ratio of McGraw Hill?

The trailing twelve-month P/E is -48.59. The Valuation tab shows it against the stock's own five-year range.

Does McGraw Hill pay a dividend?

McGraw Hill does not currently pay a regular dividend.

Is McGraw Hill a buy according to analysts?

The consensus of 8 analysts is a Buy rating, with an average 12-month price target of 16.29, which implies 35.2% upside from the current price. This is not investment advice.

What is McGraw Hill's StockVane Quant Rating?

The StockVane Momentum strategy currently rates McGraw Hill a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.

Quote time 2026-11-20 16:10:04 · For reference only, not investment advice and not tailored to your situation.

McGraw Hill discussion 0 comments

Add a comment